We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Plug Power (PLUG) to Post Q1 Earnings: What's in Store?
Read MoreHide Full Article
Plug Power Inc. (PLUG - Free Report) is scheduled to release first-quarter 2020 results on May 7, before market open.
The company delivered weaker-than-expected results twice in the last four quarters, while surpassing and meeting estimates once each. Earnings surprise for the last four quarters was a negative 25.21%, on average. Notably, in the last reported quarter, the company’s loss per share of 6 cents was in line with the Zacks Consensus Estimate.
In the past three months, shares of the company have lost 3.8% compared with the industry’s decline of 25.4%.
Factors at Play
Plug Power has been benefiting from the growing popularity of fuel-cell engines and hydrogen stations over time. This is likely to have contributed to the company’s top-line performance in the first quarter of 2020 as well. Also, its efforts to leverage its ProGen platform to expand into on-road and large-scale stationary markets are expected to have been beneficial.
Moreover, the company’s partnership with ENGIE is expected to have positively impacted its hydrogen fuel-cell business in the to-be-reported quarter. Also, Plug Power’s investment in additional capacity and sales channel is anticipated to have boosted its top-line performance. In addition, it is expected to have gained from its cost-reduction efforts and greater operational efficacy.
However, headwinds related to forex issues and geopolitical concerns, arising from international operations, are anticipated to have hurt the company’s quarterly performance. Also, higher cost of revenues and operating expenses are expected to have been dragging.
In addition, the impacts of the coronavirus outbreak on the supply chain and demand along with the governmental regulations imposed in response to the crisis are expected to get reflected in the company’s quarterly results.
The Zacks Consensus Estimate for first-quarter loss per share is pegged at 10 cents, indicating an improvement from a loss per share of 15 cents recorded in the first quarter of 2019. However, the consensus estimate for revenues of $32 million suggests a 68.4% increase from the prior-year reported figure.
Earnings Whispers
According to our quantitative model, a stock needs to have the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or at least 3 (Hold) to increase the odds of an earnings beat. But that is not the case here as we will see below.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: Plug Power has an Earnings ESP of 0.00% as both the Most Accurate Estimate and the Zacks Consensus Estimate are pegged at loss per share of 10 cents.
Axon Enterprise, Inc. currently has an Earnings ESP of +18.31% and a Zacks Rank #3.
Ball Corporation presently has an Earnings ESP of +1.56% and a Zacks Rank of 3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Plug Power (PLUG) to Post Q1 Earnings: What's in Store?
Plug Power Inc. (PLUG - Free Report) is scheduled to release first-quarter 2020 results on May 7, before market open.
The company delivered weaker-than-expected results twice in the last four quarters, while surpassing and meeting estimates once each. Earnings surprise for the last four quarters was a negative 25.21%, on average. Notably, in the last reported quarter, the company’s loss per share of 6 cents was in line with the Zacks Consensus Estimate.
In the past three months, shares of the company have lost 3.8% compared with the industry’s decline of 25.4%.
Factors at Play
Plug Power has been benefiting from the growing popularity of fuel-cell engines and hydrogen stations over time. This is likely to have contributed to the company’s top-line performance in the first quarter of 2020 as well. Also, its efforts to leverage its ProGen platform to expand into on-road and large-scale stationary markets are expected to have been beneficial.
Moreover, the company’s partnership with ENGIE is expected to have positively impacted its hydrogen fuel-cell business in the to-be-reported quarter. Also, Plug Power’s investment in additional capacity and sales channel is anticipated to have boosted its top-line performance. In addition, it is expected to have gained from its cost-reduction efforts and greater operational efficacy.
However, headwinds related to forex issues and geopolitical concerns, arising from international operations, are anticipated to have hurt the company’s quarterly performance. Also, higher cost of revenues and operating expenses are expected to have been dragging.
In addition, the impacts of the coronavirus outbreak on the supply chain and demand along with the governmental regulations imposed in response to the crisis are expected to get reflected in the company’s quarterly results.
The Zacks Consensus Estimate for first-quarter loss per share is pegged at 10 cents, indicating an improvement from a loss per share of 15 cents recorded in the first quarter of 2019. However, the consensus estimate for revenues of $32 million suggests a 68.4% increase from the prior-year reported figure.
Earnings Whispers
According to our quantitative model, a stock needs to have the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or at least 3 (Hold) to increase the odds of an earnings beat. But that is not the case here as we will see below.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: Plug Power has an Earnings ESP of 0.00% as both the Most Accurate Estimate and the Zacks Consensus Estimate are pegged at loss per share of 10 cents.
Plug Power, Inc. Price and EPS Surprise
Plug Power, Inc. price-eps-surprise | Plug Power, Inc. Quote
Zacks Rank: Plug Power carries a Zacks Rank #3.
Stocks to Consider
Here are some companies you may want to consider as our model shows that these have the right mix of elements to beat estimates this earnings season:
Intellicheck, Inc. (IDN - Free Report) has an Earnings ESP of +66.67% and a Zacks Rank of 2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Axon Enterprise, Inc. currently has an Earnings ESP of +18.31% and a Zacks Rank #3.
Ball Corporation presently has an Earnings ESP of +1.56% and a Zacks Rank of 3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>